TrialThe oncologist2025

Efficacy and safety of regorafenib plus biweekly trifluridine/tipiracil for refractory metastatic colorectal cancer: a multicenter single-arm phase II trial.

Xiangling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.